Intraneuronal APP/Aβ trafficking and plaque formation in β-amyloid precursor protein and presenilin-1 transgenic mice

Brain Pathology

Volumn 12, Issue 3, 2002, Pages 275-286

  Wirths, Oliver ^a   Multhaup, Gerd ^d   Czech, Christian ^b   Feldmann, Nicole ^a   Blanchard, Véronique ^b   Tremp, Günter ^c   Beyreuther, Konrad ^d   Pradier, Laurent ^b   Bayer, Thomas A ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b SANOFI   (France)

^c Functional Genomics   (France)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; PRESENILIN 1; ANTIBODY; MEMBRANE PROTEIN; PSEN1 PROTEIN, HUMAN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COMPARTMENTALIZATION; CONTROLLED STUDY; DENDRITIC CELL; IMMUNOHISTOCHEMISTRY; INTERNEURON; MOUSE; NERVE DEGENERATION; NEUROPIL; NEUROTRANSMITTER RELEASE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PYRAMIDAL NERVE CELL; SURFACE PLASMON RESONANCE; SYNAPTIC TRANSMISSION; TRANSGENIC MOUSE; ANIMAL; BRAIN; GENETICS; METABOLISM; MUTATION; NERVE CELL; PATHOLOGY; POLYMERASE CHAIN REACTION; PROTEIN TRANSPORT; SENILE PLAQUE; TIME; WESTERN BLOTTING;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANTIBODIES; BLOTTING, WESTERN; BRAIN; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; MUTATION; NEURONS; POLYMERASE CHAIN REACTION; PRESENILIN-1; PROTEIN TRANSPORT; SENILE PLAQUES; SURFACE PLASMON RESONANCE; TIME FACTORS;

EID: 0036019155     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2002.tb00442.x     Document Type: Article

References (63)

1. The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families
2. Early senile plaques in Down's syndrome brains show a close relationship with cell bodies of neurons
3. Plaque formation in brain transplants exposed to human beta-amyloid precursor protein 695
4. Key factors in Alzheimer's disease: Beta-amyloid precursor protein processing, metabolism and intraneuronal transport
5. Regulation of amyloid protein precursor (APP) binding to collagen and mapping of the binding sites on APP and collagen type I
6. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins
7. Regulation of APP processing by intra- and intercellular signals
8. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695
9. Alzheimer's A beta(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells
10. Proteolytical processing of mutated human amyloid precursor protein in transgenic mice
11. Proteolytic processing and cell biological functions of the amyloid precursor protein
12. Aging increased amyloid peptide and caused amyloid plaques in brain of old APP/V717I transgenic mice by a different mechanism than mutant presenilin1
13. The beta-amyloid precursor protein and its derivatives: From biology to learning and memory processes
14. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1
15. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein
16. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovasular amyloid protein
17. The amyloid deposits in Alzheimer's disease: Their nature and pathogenesis
18. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
19. Intraneuronal Abeta42 accumulation in human brain
20. Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer beta-amyloid peptides
21. Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome
22. Amyloid beta-peptide is produced by cultured cells during normal metabolism
23. Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides
24. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes
25. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models
26. Age related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins
27. Analysis of heterogeneous βA4 peptides in human cererbrospinal fluid and blood by a newly-developed sensitive Western blot assay
28. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: Evidence that an initially deposited species is A beta 42(43)
29. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell surface receptor
30. Multiple effects of aspartate mutant presenilin 1 on the processing and trafficking of amyloid precursor protein
31. Cellular signaling pathways and cytoskeletal organization
32. Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Abeta stabilization
33. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: Implications for initial events in amyloid plaque formation
34. Reduced antioxidant enzyme activity in brains of mice transgenic for human presenilin-1 with single or multiple mutations
35. Candidate gene for the chromosome 1 familial Alzheimer's disease locus
36. Endogenous serine protease inhibitor modulates epileptic activity and hippocampal long-term potentiation
37. Amyloid plaque core protein in Alzheimer disease and Down syndrome
38. Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes
39. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain
40. Expression in brain of amyloid precursor protein mutated in the alpha-secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice
41. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid
42. Mutagenesis identifies new signals for beta-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Abeta42
43. Deposition of beta/A4 protein along neuronal plasma membranes in diffuse senile plaques
44. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene
45. Homodimerization of APP and its implication in the amyloidogenic pathway of Alzheimers disease
46. Secreted amyloid b-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
47. Translating cell biology into therapeutic advances in Alzheimer's disease
48. The role of APP processing and trafficking pathways in the formation of amyloid betaprotein
49. Mechanisms of trafficking in axons and dendrites: Implications for development and neurodegeneration
50. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
51. Intracellular routing of human amyloid protein precursor: Axonal delivery followed by transport to the dendrites
52. Cellular mechanisms of beta-amyloid production and secretion
53. Detection of a novel intraneuronal pool of insoluble amyloid beta protein that accumulates with time in culture
54. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
55. The amyloid β protein gene: cDNA cloning, mRNA distribution, and genetic linkage near the Alzheimer locus
56. Neuronal sorting and processing of amyloid precursor protein: Implications for Alzheimer's disease
57. The β-amyloid domain is essential for axonal sorting of amyloid precursor protein
58. Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular beta-amyloid or A4 peptides
59. Intracellular generation and accumulation of amyloid beta-peptide terminating at amino acid 42
60. Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice
61. Generation of Alzheimer beta-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation
62. Intracellular accumulation of insoluble, newly synthesized abeta-42 in amyloid precursor protein-transfected cells that have been treated with Abeta1-42
63. The presenilin 1 proein is a component of a high molecular weight intracellular complex that contains beta-catenin